Treace Medical Concepts (TMCI) News Today $8.47 -0.22 (-2.53%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 45,923 shares of the company's stock, valuMarch 24 at 3:34 AM | marketbeat.comInsider Selling: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sells 50,000 Shares of StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) insider Sean F. Scanlan sold 50,000 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $7.97, for a total transaction of $398,500.00. Following the completion of the sale, the insider now directly owns 364,081 shares of the company's stock, valued at $2,901,725.57. The trade was a 12.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 20, 2025 | marketbeat.comSean F. Scanlan Sells 50,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockMarch 20, 2025 | insidertrades.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Up 4.7% - Should You Buy?Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% Higher - Should You Buy?March 19, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest UpdateTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 2,730,000 shares, a growth of 20.8% from the February 13th total of 2,260,000 shares. Currently, 6.1% of the company's stock are sold short. Based on an average daily volume of 373,500 shares, the short-interest ratio is currently 7.3 days.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Has $21.87 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)William Blair Investment Management LLC grew its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,938,8March 19, 2025 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Price Target Cut to $9.50 by Analysts at Truist FinancialMarch 15, 2025 | americanbankingnews.comTruist Financial Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock PriceTruist Financial dropped their price target on Treace Medical Concepts from $10.00 to $9.50 and set a "hold" rating on the stock in a research note on Thursday.March 14, 2025 | marketbeat.comJohn Treace Spends US$524k On Treace Medical Concepts StockMarch 9, 2025 | finance.yahoo.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's WhyTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's WhyMarch 6, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Hold" by BrokeragesShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus rating of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and two have assigned a buyMarch 4, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)March 3, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Given New $10.00 Price Target at Truist FinancialTruist Financial lifted their price objective on shares of Treace Medical Concepts from $8.40 to $10.00 and gave the company a "hold" rating in a research note on Monday.March 3, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | msn.comTreace Medical Concepts (TMCI) Receives a Hold from Morgan StanleyMarch 1, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Announces Earnings ResultsTreace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Treace Medical Concepts had a negative net margin of 30.33% and a negative return on equity of 51.12%.February 28, 2025 | marketbeat.comTreace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Treace Medical Concepts (TMCI) and Jasper Therapeutics (JSPR)February 27, 2025 | markets.businessinsider.comTreace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial ResultsFebruary 27, 2025 | markets.businessinsider.comTreace Medical Concepts (TMCI) Expected to Announce Quarterly Earnings on ThursdayTreace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)February 20, 2025 | marketbeat.comInsider Stock Buying Reaches US$7.31m On Treace Medical ConceptsFebruary 8, 2025 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by AnalystsTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendationFebruary 7, 2025 | marketbeat.comTreace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025February 6, 2025 | globenewswire.comWhy Treace Medical Concepts (TMCI) Is Rallying TodayFebruary 5, 2025 | msn.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Should You Buy?Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's What HappenedFebruary 4, 2025 | marketbeat.comTreace Medical upgraded to Buy from Neutral at BTIGFebruary 4, 2025 | markets.businessinsider.comBTIG raises Treace Medical stock to Buy, sets $16 targetFebruary 4, 2025 | msn.comPositive Report for Treace Medical Concepts (TMCI) from BTIGFebruary 4, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Stock Rating Upgraded by BTIG ResearchBTIG Research raised shares of Treace Medical Concepts from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Tuesday.February 4, 2025 | marketbeat.comTreace Medical announces completion of first cases using SpeedAkin ACIJanuary 30, 2025 | markets.businessinsider.comTreace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression ImplantJanuary 30, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Shares Up 5.1% - Time to Buy?Treace Medical Concepts (NASDAQ:TMCI) Trading Up 5.1% - Time to Buy?January 27, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by Barclays PLCBarclays PLC boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 352.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 79,696 shares of the company's stock after purchasing an additional 62,073 shares during tJanuary 19, 2025 | marketbeat.comJPMorgan Chase & Co. Has $7.32 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)JPMorgan Chase & Co. raised its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 215.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,262,235 shares of the company's stock after buying an additionalJanuary 15, 2025 | marketbeat.comTruist Financial Reaffirms Their Hold Rating on Treace Medical Concepts (TMCI)January 15, 2025 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)January 14, 2025 | markets.businessinsider.comTreace Medical Concepts (TMCI) Receives a Hold from Stifel NicolausJanuary 14, 2025 | markets.businessinsider.comTreace Medical Preliminary Q4, FY24 Revenues Beat Expectations; Stock UpJanuary 13, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - Still a Buy?Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - What's Next?January 13, 2025 | marketbeat.comTreace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 RevenueJanuary 13, 2025 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Hold" by BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received an average recommendation of "Hold" from the seven analysts that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and one has issued a buy rating on the cJanuary 13, 2025 | marketbeat.comThe Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsJanuary 9, 2025 | businesswire.comTreace to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | globenewswire.comLake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy RecommendationJanuary 1, 2025 | msn.comTreace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street CapitalLake Street Capital started coverage on Treace Medical Concepts in a research report on Tuesday. They issued a "buy" rating and a $14.50 price target for the company.December 31, 2024 | marketbeat.comTreace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® ProcedureDecember 30, 2024 | globenewswire.comWith 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big gunsDecember 29, 2024 | uk.finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Hold" from BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received a consensus recommendation of "Hold" from the six brokerages that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average twelve-month price objective among anDecember 19, 2024 | marketbeat.comDeep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)December 18, 2024 | benzinga.comTruist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) StockTruist Financial increased their price objective on Treace Medical Concepts from $7.00 to $8.40 and gave the company a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.com Remove Ads Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address TMCI Media Mentions By Week TMCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼0.730.63▲Average Medical News Sentiment TMCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼83▲TMCI Articles Average Week Remove Ads Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LeMaitre Vascular News CONMED News Cadre News Tandem Diabetes Care News InMode News Liquidia News BioLife Solutions News MiMedx Group News Establishment Labs News Paragon 28 News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.